Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe

Chimeric antigen receptor (CAR)-T cell therapy is a new class of cellular immunotherapies that involves ex vivo genetic modification of T cells to incorporate an engineered CAR. After infusion into the patient, the CAR-expressing T cells recognize specific tumor targets and induce an immune response...

Descripción completa

Detalles Bibliográficos
Autores principales: Buechner, Jochen, Kersten, Marie José, Fuchs, Miriam, Salmon, Florence, Jäger, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745952/
https://www.ncbi.nlm.nih.gov/pubmed/31723747
http://dx.doi.org/10.1097/HS9.0000000000000018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745952/
https://www.ncbi.nlm.nih.gov/pubmed/31723747
http://dx.doi.org/10.1097/HS9.0000000000000018

Ejemplares similares